TGFB1 and leiomyoma: In conclusion, the adherent junction, ECM-receptor interaction, TGFβ, and cell cycle pathways drive the onset and the development of leiomyoma, not only in differentiated cells and tissues as previously reported, but also at the mesenchymal level where their alterations are already detectable.